Active surveillance cost-effective for prostate cancer
(HealthDay) -- In a theoretical cohort of 120,000 men, selecting active surveillance for prostate cancer results in considerable cost savings at five and 10 years of follow-up, compared with immediate treatment, according ...
Jul 13, 2012
0
0